 |
|
Protein key to control, growth of blood cells
August 14, 2008Findings may aid in bone marrow transplants, blood diseases
New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and may lead to better treatments for life-threatening blood diseases.
"As we better understand the biological pathways that regulate the growth of stem cells, we may identify new approaches for treating blood disorders," said study leader Wei Tong, Ph.D., a hematology researcher at The Children's Hospital of Philadelphia. Her study appeared online July 10 in the Journal of Clinical Investigation.
Hematopoietic stem cells (HSCs) develop into all types of blood cells: red blood cells, platelets and immune cells. HSCs, like other stem cells, have the ability to self-renew: each can give rise to more mature, developed cells with more specific functions, as well as a new stem cell. (Everyone carries HSCs in their bone marrow, unlike embryonic stem cells, which exist only in embryos.)
In her study, conducted in mice, Tong focused on a protein called Lnk that helps control HSC expansion. When a growth factor in the blood called thrombopoietin (TPO) acts on its cell receptor, it triggers signals along a pathway that includes another protein, JAK2. JAK2, in turn, causes stem cells to increase their numbers.
Tong's group and others previously found that Lnk is a negative regulator for HSCs, acting as a brake on stem cell expansion. In the current study, they found that mice genetically engineered to lack the Lnk protein had 10 times the normal amount of HSCs in their bone marrow. Without Lnk to directly interact with JAK2 and inhibit its activity, TPO made stem cell production go into overdrive.
However, there was an unexpected potential benefit-- the expanded population of stem cells had a higher proportion of quiescent cells, those in a resting stage in the cell cycle. Quiescent stem cells, said Tong, are more likely to succeed in a recipient when they are used in bone marrow transplantation.
Although much research remains to be done, added Tong, other researchers might build on this knowledge to manipulate HSCs for more effective bone marrow transplants for cancer patients after high-dose chemotherapy or radiotherapy. It might also improve treatments for particular blood disorders. For example, aplastic anemia, severe combined immunodeficiency disorders and hemoglobin disorders involve deficiencies of specific immune cells in the blood. Using a drug to inhibit Lnk could potentially produce larger numbers of HSCs for a successful bone marrow transplant.
Myeloproliferative disorders (MPDs), on the other hand, entail the opposite danger-a sometimes-fatal overproduction of certain bone marrow cells. Clinicians might use Tong's research on Lnk and its associated signaling pathway to curtail stem cell production and control MPDs.
Children's Hospital of Philadelphia
Hematopoietic stem cells (HSCs) develop into all types of blood cells: red blood cells, platelets and immune cells. HSCs, like other stem cells, have the ability to self-renew: each can give rise to more mature, developed cells with more specific functions, as well as a new stem cell. (Everyone carries HSCs in their bone marrow, unlike embryonic stem cells, which exist only in embryos.)
In her study, conducted in mice, Tong focused on a protein called Lnk that helps control HSC expansion. When a growth factor in the blood called thrombopoietin (TPO) acts on its cell receptor, it triggers signals along a pathway that includes another protein, JAK2. JAK2, in turn, causes stem cells to increase their numbers.
Tong's group and others previously found that Lnk is a negative regulator for HSCs, acting as a brake on stem cell expansion. In the current study, they found that mice genetically engineered to lack the Lnk protein had 10 times the normal amount of HSCs in their bone marrow. Without Lnk to directly interact with JAK2 and inhibit its activity, TPO made stem cell production go into overdrive.
However, there was an unexpected potential benefit-- the expanded population of stem cells had a higher proportion of quiescent cells, those in a resting stage in the cell cycle. Quiescent stem cells, said Tong, are more likely to succeed in a recipient when they are used in bone marrow transplantation.
Although much research remains to be done, added Tong, other researchers might build on this knowledge to manipulate HSCs for more effective bone marrow transplants for cancer patients after high-dose chemotherapy or radiotherapy. It might also improve treatments for particular blood disorders. For example, aplastic anemia, severe combined immunodeficiency disorders and hemoglobin disorders involve deficiencies of specific immune cells in the blood. Using a drug to inhibit Lnk could potentially produce larger numbers of HSCs for a successful bone marrow transplant.
Myeloproliferative disorders (MPDs), on the other hand, entail the opposite danger-a sometimes-fatal overproduction of certain bone marrow cells. Clinicians might use Tong's research on Lnk and its associated signaling pathway to curtail stem cell production and control MPDs.
Children's Hospital of Philadelphia
Bone Marrow Current Events and Bone Marrow News RSSBone Implant Offers Hope for Skull Deformities
A synthetic bone matrix offers hope for babies born with craniosynostosis, a condition that causes the plates in the skull to fuse too soon.
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.
Scientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection.
Stem cell therapy may offer hope for acute lung injury
Researchers at the University of Illinois at Chicago College of Medicine have shown that adult stem cells from bone marrow can prevent acute lung injury in a mouse model of the disease.
New insight in the fight against the Leishmania parasite
Professor Albert Descoteaux's team at Centre INRS - Institut Armand-Frappier has gained a better understanding of how the Leishmania donovani parasite manages to outsmart the human immune system and proliferate with impunity, causing visceral leishmaniasis, a chronic infection that is potentially fatal if left untreated.
2-million-year-old evidence shows tool-making hominins inhabited grassland environments
In an article published in the open-access, peer-reviewed journal PLoS ONE on October 21, 2009, Dr Thomas Plummer of Queens College at the City University of New York, Dr Richard Potts of the Smithsonian Institution National Museum of Natural History and colleagues report the oldest archeological evidence of early human activities in a grassland environment, dating to 2 million years ago.
Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy
The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover - the skin, nails, bone marrow, lungs and gut.
Strategy for mismatched stem cell transplants triggers protection against graft-vs.-host disease
A new technique being tested in stem-cell transplants from imperfectly matched donors has revealed a striking, unforeseen response that can suppress graft-versus-host disease, a common and dangerous complication of mismatched transplants, report scientists from Dana-Farber Cancer Institute.
Multivisceral transplant survival rates improve with new treatment, says Pittsburgh study
Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management.
More Bone Marrow Current Events and Bone Marrow News Articles
 |
Bone Marrow Immunohistochemistry by Emina Emilia Torlakovic (Author), Kikkeri N Naresh (Author), Richard D Brunning (Author) Bone Marrow IHC provides a rich collection of color illustrations that demonstrate the diagnostic features of antibodies applicable to bone marrow tissue. Each of the antibodies illustrated in the volume includes a systematic description that details an expected reaction profile in both normal bone marrow cells and neoplastic cells, as well as authoritative advice about avoiding potential diagnostic pitfalls and technical problems related to the antibodies and tissue processing. A completely practical volume for pathologists and pathology residents alike, Bone Marrow IHC presents a methodological approach. Included are critical reviews of most of the IHC tests in use today, as well as summaries of expected reactivities in normal and diseased bone marrow. Also included is information... |
 |
Lamaur Bone Marrow Conditioner by Lamaur Deep Penetrating Treatment after coloring, bleaching, perming, or any other salon service. For proper hair maintenance, use on a regular once-a-week basis to keep hair moisturized, conditioned and in manageable condition. For severely damaged hair, use every other day. |
 |
Milk-Bone Original Crunchy Marrow Filled Treats For Dogs by Milk Bone Milk-Bone Original Crunchy Marrow Filled Treats For Dogs are made with succulent bone marrow that dogs crave! Their small size make them perfect for training. |
 |
The Marrow of a Bone by Dir en grey Following up to the world-wide smash hit album, 'Withering To Death', Dir en grey is releasing, 'The Marrow of a Bone.' It includes the single track, 'Agitated Screams of Maggots', 'CLEVER SLEAZOID', 'Ryojoku no Ame,' and more! This Limited edition also includes bonus CD with classical arrangements of the album tracks. Sony. 2006. |
![The Marrow Of A Bone [Explicit]](http://ecx.images-amazon.com/images/I/41Dy7rkxNVL._SL160_.jpg) |
The Marrow Of A Bone [Explicit] Dir En Grey (Primary Contributor) |
 |
Bone Marrow Pathology by Anesoft (Author), Kathryn Foucar (Author) Already a standard in the field, the new edition of Bone Marrow Pathology incorporates the latest WHO classification system to present an integrative approach that fosters superior interpretation. Illustrated with more than 800 color images integrated into the discussions, the text reviews basic epidemiologic, clinical and hematologic findings in disorders, as well as addressing smear and section interpretation. This practical tool includes tips, clues, and caveats in diagnosis. |
 |
Bone Marrow Donation Awareness Ribbon Mouse Pad by MyHeritageWear.com The Bone Marrow Donation Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Bone Marrow Donation Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Bone Marrow Donation Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
|
The New Normal Life After Bone Marrow Stem Cell Transplant a compelling story of six transplant survivors | |
 |
5½" Marrow Action Figure with Detachable Bone Weaponry! - Marvel Comics X-Men Generation X - Gen-X Display Base Included! by Toy Biz, Inc. To survive a devastating attack upon them, a group of Morlocks - exiled mutants living beneath the street of Manhattan - were teleported to another dimension. Enraged at being driven from their home, a twisted young woman called Marrow devised a means to return to Earth and exact revenge upon those she held responsible: humans! Dead set on destruction, Marrow will use her mutant ability to rend bone weapons from her own body against anyone who gets in her way! |
 |
Allegiance Tray Biopsy, Bone Marrow 11gx4" 10/cs by Allegiance ALLEGIANCE TRAY BIOPSY, BONE MARROW 11GX4" 10/CS : ALLEGIANCE TRAY BIOPSY, BONE MARROW 11GX4" 10/CS |
| © 2009 BrightSurf.com |